Tonix Pharma (TNXP) PT Lowered to $1.50 at Noble Capital
Tweet Send to a Friend
Noble Capital analyst Robert LeBoyer lowered the price target on Tonix Pharma (NASDAQ: TNXP) to $1.50 (from $10.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
